chitosan has been researched along with Leukemia, Lymphocytic, T Cell in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asundi, A; Elsa Mohan, R; Lang, MJ; Ngeow, YK; Patil, A; Sarangapani, S | 1 |
| Chattopadhyay, S; Das, B; Das, D; Dash, SK; Ghosh, T; Kar Mahapatra, S; Pramanik, P; Roy, S; Tripathy, S | 1 |
| Baum, LG; Belitsky, JM; Joiner, CS; Nelson, A; Stoddart, JF; Vidal, S | 1 |
3 other study(ies) available for chitosan and Leukemia, Lymphocytic, T Cell
| Article | Year |
|---|---|
Chitosan nanoparticles' functionality as redox active drugs through cytotoxicity, radical scavenging and cellular behaviour.
Topics: Apoptosis; Biological Transport, Active; Caspases; Cell Proliferation; Chitosan; Drug Delivery Systems; Free Radical Scavengers; Glutathione; HEK293 Cells; Humans; Jurkat Cells; Leukemia, T-Cell; Materials Testing; Nanoparticles; Nanotechnology; Oxidation-Reduction; Oxidative Stress; Reactive Oxygen Species | 2018 |
Chitosan-modified cobalt oxide nanoparticles stimulate TNF-α-mediated apoptosis in human leukemic cells.
Topics: Apoptosis; Chitosan; Cobalt; Dose-Response Relationship, Drug; Humans; Jurkat Cells; Leukemia, T-Cell; Lymphocytes; Metal Nanoparticles; Oxides; Tumor Necrosis Factor-alpha; X-Ray Diffraction | 2014 |
A self-assembled multivalent pseudopolyrotaxane for binding galectin-1.
Topics: Agglutination Tests; alpha-Cyclodextrins; Carbohydrate Sequence; Cell Line, Tumor; Chitosan; Galectin 1; Glycosides; Humans; Leukemia, T-Cell; Molecular Sequence Data; Recombinant Proteins; Rotaxanes; T-Lymphocytes; Viologens | 2004 |